INTS7 is a nuclear backbone subunit of the Integrator complex with conserved roles in cell proliferation and signaling during development, established by its Drosophila ortholog deflated whose loss produces pleiotropic developmental defects consistent with perturbed cell signaling and proliferation (PMID:19326441). In mammalian cells, INTS7 supports proliferation by suppressing oxidative stress: it physically interacts with ABCD3 in bone marrow mesenchymal stem cells, and disruption of this interaction raises ROS and γ-H2AX, induces apoptosis, and shifts the balance from osteoblastic toward adipogenic differentiation (PMID:34880777). INTS7 stability is governed by BAG3, which binds INTS7 and prevents its proteasomal ubiquitination; restoring INTS7 rescues the proliferation deficit caused by BAG3 loss, placing INTS7 downstream of BAG3 in a pathway controlling stem cell expansion through oxidative stress control (PMID:37576499). INTS7 also operates at the chromatin/genome-stability interface: its loss in embryonic stem cells elevates DNA damage, drives Kap1 phosphorylation, increases chromatin accessibility at MERVL retrovirus loci, and activates a p53–Dux transcriptional axis to induce MERVL expression alongside caspase-3 cleavage and anastasis (PMID:40842237). At the transcriptional level, INTS7 is regulated from a bidirectional intergenic promoter shared with CDT2, where B-Myb, c-Myb, and p53 down-regulate INTS7 expression (PMID:18213392).